QuanBio was founded on the belief that cardiovascular physiology is continuous, yet modern medicine still relies on fragmented signals and delayed data. Our mission is to decode hemodynamics in real time, delivering a unified view of human health from foundational population screening to acute surgical recovery.
By combining advanced vascular physics with our proprietary Biological AI, we transform continuous streaming into predictive intelligence across the full recovery arc. Built on a solid foundation of population screening, we are creating the next generation of cardiovascular care driven by continuous physiologic analysis, deep longitudinal phenotyping, and the early recognition of evolving clinical instability.
Built On Clinical & Scientific Rigor
QuanBio’s work is grounded in cardiovascular science, clinical collaboration, and responsible longitudinal data development.
The company is focused on delivering predictive physiologic insights that are rigorous, interpretable, and clinically meaningful across healthcare, cardiovascular research, and life-science applications.
Where Cardiovascular Medicine Meets Computational Science
QuanBio brings together world-class expertise across cardiovascular medicine, vascular science, hemodynamics, physiologic signal analysis, engineering, and advanced machine learning.
The company operates at the intersection of real-world clinical medicine and computational physiology — combining deep understanding of vascular function and hemodynamic behavior with biologically grounded AI to decode cardiovascular instability, recovery dynamics, and longitudinal physiologic change in real time.
This multidisciplinary foundation enables QuanBio to bridge cardiovascular science, clinical care, and longitudinal real-world evidence generation across healthcare and life-science applications.
